“In Parkinson patients melatonin may, on the one hand, exacerbate symptoms (because of its putative interference with dopamine release ) and, on the other, protect against neurodegeneration (by virtue of its antioxidant properties and its effects on mitochondrial activity).”
“Inhibition of dopamine release by melatonin has been demonstrated in specific areas of the mammalian central nervous system (hypothalamus, hippocampus, medulla-pons, and retina).”